CLASS II ONGOING Device recall · Reported 12 Aug 2026 · FDA Enforcement Report

HardyDisk AST Cefiderocol 30¿g (FDC30) recalled by Hardy Diagnostics

Hardy Diagnostics is recalling HardyDisk AST Cefiderocol 30¿g (FDC30), distributed nationwide in the US. The recall was initiated on 8 Jun 2026 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesCatalog Number: Z9435 UD-DI code: Pending Lot Number: 543461
Quantity recalled43 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2887-2026
FDA event ID
99226
Recalling firm
Hardy Diagnostics, Santa Maria, CA
Classification
Class II
Status
Ongoing
Recall initiated
8 Jun 2026
FDA classified
5 Aug 2026
Reported
12 Aug 2026
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Lead & Heavy Metals

Timeline

8 Jun 2026Recall initiated by company
5 Aug 2026Classified by FDA+58 days
12 Aug 2026Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Due to incorrect cartridges include in affected products that there is the potential for false-susceptible or false-resistant susceptibility results and may lead to selection of an ineffective antimicrobial therapy, potentially resulting in delayed appropriate treatment, prolonged infection, or worsening clinical outcome.

Lead and other heavy metals accumulate in the body. Children are most at risk; even low levels can affect development.

Product as listed by the FDA

HardyDisk AST Cefiderocol 30¿g (FDC30) REF Z9435 HardyDisk AST Cefiderocol 30¿g (FDC30) for in vitro agar diffusion susceptibility testing is indicated when there is the need to determine the susceptibility of Enterobacterales, Pseudomonas aeruginosa, Acinetobacter baumannii complex and Stenotrophomonas maltophilia to Cefiderocol,

Where it was distributed

U.S. Nationwide distribution in the states of AZ, CA, FL, ID, IN, MA, MS, NJ, NV, NY, OH, PA, and TN.

Nationwide ArizonaCaliforniaFloridaIdahoIndianaMassachusettsMississippiNew JerseyNevadaNew YorkOhioPennsylvaniaTennessee

Questions about this recall

Is HardyDisk AST Cefiderocol 30¿g (FDC30) recalled?

Yes. Hardy Diagnostics recalled HardyDisk AST Cefiderocol 30¿g (FDC30) on 8 Jun 2026. The recall is Class II and its status is Ongoing. Recall number Z-2887-2026.

Why was it recalled?

Due to incorrect cartridges include in affected products that there is the potential for false-susceptible or false-resistant susceptibility results and may lead to selection of an ineffective antimicrobial therapy, potentially resulting in delayed appropriate treatment, prolonged infection, or worsening clinical outcome.

Which lots are affected?

Catalog Number: Z9435 UD-DI code: Pending Lot Number: 543461

Where was it sold?

U.S. Nationwide distribution in the states of AZ, CA, FL, ID, IN, MA, MS, NJ, NV, NY, OH, PA, and TN.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Hardy Diagnostics

All 20

Other Test Kits & Diagnostics recalls

All 2,656